Advertisement
<< Back To Article
HIV Study Notes More Cardiovascular Disease in Long-Term Nonprogressors

Write a Comment

I have read and agree to the terms and conditions in the Posting Rules*

3 Comments

David Phillips

Where was the critical review at ICAAC that should have sent the research back to the scientist for insufficient evidence? As Loreen and Rob have noted, the ridiculously small sample size is not valid for drawing widespread conclusion; yet, POZ and other media have taken the bait. As a viremic controller of over 28 years, I also find the quoted distribution of HIV controllers misleading, as the HIV Controllers site notes the correct distribution as 1 in 300 -- that's a three-fold variance!

September 24, 2010 College Park, MD

Loreen Willenberg

The conclusions of this under-powered study (n=26) are overshadowed by the exlusion of true LTNPs, and the inclusion of chronic progressors and slow progressors of HIV. Concrete definitions of these groups can be located in a paper by Drs. Connors & Migueles (NIH) in JAMA.2010;304(2)pp.194-201, published on July 14, 2010. Data generated by a larger cohort of true LTNPs is needed to convince me that CVD risk is higher in my unique community.

September 22, 2010 Sacramento

Rob Cohen

This is an extremely small sample size. As an elite controller with CD4s maintained at 800 or above for 24 years, consistently undetectable viral load, and ARV and HAART naive, I do not (yet) take it seriously. A much larger sample with participants who are clearly in the elite controller category or LTNP category might prove interesting. References for elite controller & LTNP www.hivcontrollers.org/hivcontrollers aidsinfo.nih.gov/ContentFiles/GlossaryHIVrelatedTerms.pdf

September 21, 2010 San Francisco, CA

Advertisement

Hot topics


POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.